Skip to main content
. 2013 Jul 13;105(16):1230–1238. doi: 10.1093/jnci/djt181

Table 2.

Secondary endpoints change from baseline*

Variable (range: 0–100, higher is better) Data Point Ginseng (SD) Placebo (SD) P
MFSI-SF Physical 4 weeks† 1.6 (15.9) −0.4 (14.7) .39
8 weeks‡ 3.0 (17.9) −1.7 (18.2) .004
MFSI-SF Mental 4 weeks† 2.0 (15.2) 0.6 (16.1) .41
8 weeks‡ 2.8 (16.5) 3.4 (15.2) .80
MFSI-SF Emotional 4 weeks† 0.5 (16.1) 0.5 (16.7) .99
8 weeks‡ 3.0 (17.4) 2.3 (17.4) .68
MFSI-SF Vigor 4 weeks† 1.8 (19.0) 0.4 (15.5) .70
8 weeks‡ 4.6 (20.5) 2.5 (17.6) .71
MFSI-SF total score 4 weeks† 4.1 (13.4) 2.1 (12.9) .21
8 weeks‡ 6.7 (14.0) 3.7 (14.6) .02
POMS
 Fatigue inertia 4 weeks§ 14.5 (25) 7.7 (23.6) .08
8 weeks|| 18.6 (24.8) 10.2 (26.1) .008
 Vigor activity 4 weeks§ 5 (18.7) 3.9 (17.3) .79
8 weeks|| 8.2 (19.8) 6.4 (19.8) .47

* MFSI = Multidimensional Fatigue Symptom Inventory–Short Form; POMS = Profile of Mood States; SD = standard deviation.

† n = 147 in the ginseng arm and n = 152 in the placebo arm at 4 weeks.

‡ n = 138 in the ginseng arm and n = 132 in the placebo arm at 8 weeks.

§ n = 139 in the ginseng arm and n = 142 in the placebo arm at 4 weeks.

|| n = 132 in the ginseng arm and n = 128 in the placebo arm at 8 weeks.